Chicago, IL, United States of America

Henry E Auer


Average Co-Inventor Count = 4.9

ph-index = 6

Forward Citations = 358(Granted Patents)


Location History:

  • Terre Haute, IN (US) (1998)
  • Belmont, MA (US) (1997 - 1999)
  • Chicago, IL (US) (2000 - 2003)
  • Watertown, MA (US) (2003)

Company Filing History:


Years Active: 1997-2003

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Henry E. Auer

Introduction

Henry E. Auer is a notable inventor based in Chicago, IL, with a remarkable portfolio of eight patents. His work primarily focuses on the development of biologically active molecules and drug delivery systems. Auer's innovative approaches have significantly contributed to advancements in the field of pharmaceuticals.

Latest Patents

Among his latest patents is a process for producing small particles of biologically active molecules. This process involves atomizing solutions of the molecules through a nozzle into very cold liquefied gases, which immediately freeze the atomized droplets. The resulting frozen particles, with diameters ranging from approximately 10 to 90 micrometers, are lyophilized to create porous particles. These particles are then suspended in a non-solvent for the molecules and exposed to ultrasonic energy or homogenization, resulting in particles with diameters of 0.1 to 10 micrometers while retaining 70 to 95% of the initial biological activity of the molecules in solution.

Another significant patent is a device for the sustained release of aggregation-stabilized, biologically active agents. This device is designed for the in vivo sustained release of a water-soluble, biologically active agent that is susceptible to aggregation. The drug delivery device contains the aggregation-stabilized agent, ensuring effective delivery and stability.

Career Highlights

Henry E. Auer has worked with prominent companies in the pharmaceutical industry, including Alkermes Controlled Therapeutics, Inc. and Alkermes, Inc. His contributions to these organizations have been instrumental in advancing drug delivery technologies and improving patient outcomes.

Collaborations

Auer has collaborated with notable professionals in his field, including OluFunmi Lily Johnson and Howard Bernstein. These partnerships have fostered innovation and enhanced the development of his patented technologies.

Conclusion

Henry E. Auer's contributions to the field of biologically active molecules and drug delivery systems highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to advancing pharmaceutical technologies that benefit society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…